COPD is highly prevalent but under-diagnosed in patients with heart failure, atrial fibrillation, and ischemic heart disease, and its appropriate management improves cardiovascular outcomes by reducing hyperinflation and preventing acute exacerbations.
COPD is highly prevalent but underdiagnosed in patients with cardiovascular disease, and its appropriate management can improve cardiac function, reduce hyperinflation, and prevent exacerbation-related cardiovascular mortality.
Globally, cardiovascular diseases and chronic obstructive pulmonary disease (COPD) are the leading causes of the noncommunicable disease burden. Overlapping symptoms such as breathing difficulty and fatigue, with a lack of awareness about COPD among physicians, are key reasons for under-diagnosis and resulting sub-optimal care relative to COPD. Much has been published in the past on the pathogenesis and implications of cardiovascular comorbidities in COPD. However, a comprehensive review of the prevalence and impact of COPD management in commonly encountered cardiac diseases is lacking. The purpose of this study was to summarize the current knowledge regarding the prevalence of COPD in heart failure, ischemic heart disease, and atrial fibrillation. We also discuss the real-life clinical presentation and practical implications of managing COPD in cardiac diseases. We searched PubMed, Scopus, EMBASE, and Google Scholar for studies published 1981-May 2020 reporting the prevalence of COPD in the three specified cardiac diseases. COPD has high prevalence in heart failure, atrial fibrillation, and ischemic heart disease. Despite this, COPD remains under-diagnosed and under-managed in the majority of patients with cardiac diseases. The clinical implications of the diagnosis of COPD in cardiac disease includes the recognition of hyperinflation (a treatable trait), implementation of acute exacerbations of COPD (AECOPD) prevention strategies, and reducing the risk of overuse of diuretics. The pharmacological agents for the management of COPD have shown a beneficial effect on cardiac functions and mortality. The appropriate management of COPD improves the cardiovascular outcomes by reducing hyperinflation and preventing AECOPD, thus reducing the risk of mortality, improving exercise tolerance, and quality of life.
Deshmukh et al. (Tue,) conducted a review in Cardiovascular diseases and Chronic Obstructive Pulmonary Disease (COPD). COPD and its management was evaluated. COPD is highly prevalent but under-diagnosed in patients with heart failure, atrial fibrillation, and ischemic heart disease, and its appropriate management improves cardiovascular outcomes by reducing hyperinflation and preventing acute exacerbations.